170 related articles for article (PubMed ID: 32632900)
1. The Ratio of ssDNA to dsDNA in Circulating Cell-Free DNA Extract is a Stable Indicator for Diagnosis of Gastric Cancer.
Huang X; Zhao Q; An X; Pan J; Zhao L; Shen L; Xu Y; Yuan D
Pathol Oncol Res; 2020 Oct; 26(4):2621-2632. PubMed ID: 32632900
[TBL] [Abstract][Full Text] [Related]
2. Clinical significance of cell-free DNA concentration and integrity in serum of gastric cancer patients before and after surgery.
Zhang X; Wu Z; Shen Q; Li R; Jiang X; Wu J; Li D; Wang D; Zou C; Zhong Y; Cheng X
Cell Mol Biol (Noisy-le-grand); 2019 Sep; 65(7):111-117. PubMed ID: 31880527
[TBL] [Abstract][Full Text] [Related]
3. Enhanced detection of cell-free DNA (cfDNA) enables its use as a reliable biomarker for diagnosis and prognosis of gastric cancer.
Bu J; Lee TH; Jeong WJ; Poellmann MJ; Mudd K; Eun HS; Liu EW; Hong S; Hyun SH
PLoS One; 2020; 15(12):e0242145. PubMed ID: 33264292
[TBL] [Abstract][Full Text] [Related]
4. Hsa_circ_0065149 is an Indicator for Early Gastric Cancer Screening and Prognosis Prediction.
Shao Y; Tao X; Lu R; Zhang H; Ge J; Xiao B; Ye G; Guo J
Pathol Oncol Res; 2020 Jul; 26(3):1475-1482. PubMed ID: 31432324
[TBL] [Abstract][Full Text] [Related]
5. Determination of serum RP11-731F5.2 as a noninvasive biomarker for gastric cancer diagnosis and prognosis.
Jing R; Liu S; Jiang Y; Zong W; Ju S; Cui M
Pathol Res Pract; 2020 Dec; 216(12):153261. PubMed ID: 33176259
[TBL] [Abstract][Full Text] [Related]
6. Long noncoding RNA HOXA11-AS promotes gastric cancer cell proliferation and invasion
Liu Y; Zhang YM; Ma FB; Pan SR; Liu BZ
World J Gastroenterol; 2019 Jun; 25(22):2763-2775. PubMed ID: 31235999
[TBL] [Abstract][Full Text] [Related]
7. Function of Long Noncoding RNA UCA1 on Gastric Cancer Cells and its Clinicopathological Significance in Plasma.
Tang X; Yu L; Bao J; Jiang P; Yan F
Clin Lab; 2019 Nov; 65(11):. PubMed ID: 31710437
[TBL] [Abstract][Full Text] [Related]
8. Liquid Biopsy in Gastric Cancer: Analysis of Somatic Cancer Tissue Mutations in Plasma Cell-Free DNA for Predicting Disease State and Patient Survival.
Varkalaite G; Forster M; Franke A; Kupcinskas J; Skieceviciene J
Clin Transl Gastroenterol; 2021 Sep; 12(9):e00403. PubMed ID: 34644276
[TBL] [Abstract][Full Text] [Related]
9. Gastric juice piR-1245: A promising prognostic biomarker for gastric cancer.
Zhou X; Liu J; Meng A; Zhang L; Wang M; Fan H; Peng W; Lu J
J Clin Lab Anal; 2020 Apr; 34(4):e23131. PubMed ID: 31777102
[TBL] [Abstract][Full Text] [Related]
10. Circulating nuclear DNA structural features, origins, and complete size profile revealed by fragmentomics.
Sanchez C; Roch B; Mazard T; Blache P; Dache ZAA; Pastor B; Pisareva E; Tanos R; Thierry AR
JCI Insight; 2021 Apr; 6(7):. PubMed ID: 33571170
[TBL] [Abstract][Full Text] [Related]
11. Circulating cell-free DNA variables as marker of ovarian cancer patients: A pilot study.
Stamenkovic S; Cheng J; Surowy H; Burwinkel B; Gündert M
Cancer Biomark; 2020; 28(2):159-167. PubMed ID: 32176629
[TBL] [Abstract][Full Text] [Related]
12. Characteristics, origin, and potential for cancer diagnostics of ultrashort plasma cell-free DNA.
Hudecova I; Smith CG; Hänsel-Hertsch R; Chilamakuri CS; Morris JA; Vijayaraghavan A; Heider K; Chandrananda D; Cooper WN; Gale D; Garcia-Corbacho J; Pacey S; Baird RD; Rosenfeld N; Mouliere F
Genome Res; 2022 Feb; 32(2):215-227. PubMed ID: 34930798
[TBL] [Abstract][Full Text] [Related]
13. Circulating SHIP2 mRNA as a novel biomarker in the diagnosis and prognosis of gastric cancer.
Xie JF; Xie NS; Tang JH; Gu QP; Luo QT
Eur Rev Med Pharmacol Sci; 2017 Nov; 21(22):5129-5134. PubMed ID: 29228424
[TBL] [Abstract][Full Text] [Related]
14. Single-stranded DNA library preparation uncovers the origin and diversity of ultrashort cell-free DNA in plasma.
Burnham P; Kim MS; Agbor-Enoh S; Luikart H; Valantine HA; Khush KK; De Vlaminck I
Sci Rep; 2016 Jun; 6():27859. PubMed ID: 27297799
[TBL] [Abstract][Full Text] [Related]
15. Circulating Exosomal Gastric Cancer-Associated Long Noncoding RNA1 as a Biomarker for Early Detection and Monitoring Progression of Gastric Cancer: A Multiphase Study.
Guo X; Lv X; Ru Y; Zhou F; Wang N; Xi H; Zhang K; Li J; Chang R; Xie T; Wang X; Li B; Chen Y; Yang Y; Chen L; Chen L
JAMA Surg; 2020 Jul; 155(7):572-579. PubMed ID: 32520332
[TBL] [Abstract][Full Text] [Related]
16. The value of serum RASSF10 hypermethylation as a diagnostic and prognostic tool for gastric cancer.
Xue WJ; Feng Y; Wang F; Li P; Liu YF; Guo YB; Wang ZW; Mao QS
Tumour Biol; 2016 Aug; 37(8):11249-57. PubMed ID: 26945573
[TBL] [Abstract][Full Text] [Related]
17. Genome-wide long non-coding RNAs identified a panel of novel plasma biomarkers for gastric cancer diagnosis.
Zheng R; Liang J; Lu J; Li S; Zhang G; Wang X; Liu M; Wang W; Chu H; Tao G; Zhao Q; Wang M; Du M; Qiang F; Zhang Z
Gastric Cancer; 2019 Jul; 22(4):731-741. PubMed ID: 30603909
[TBL] [Abstract][Full Text] [Related]
18. The Association of HOTAIR with the Diagnosis and Prognosis of Gastric Cancer and Its Effect on the Proliferation of Gastric Cancer Cells.
Xu Z; Chen H; Yang B; Liu X; Zhou X; Kong H
Can J Gastroenterol Hepatol; 2019; 2019():3076345. PubMed ID: 31281803
[TBL] [Abstract][Full Text] [Related]
19. CircRNA microarray profiling identifies a novel circulating biomarker for detection of gastric cancer.
Tang W; Fu K; Sun H; Rong D; Wang H; Cao H
Mol Cancer; 2018 Sep; 17(1):137. PubMed ID: 30236115
[TBL] [Abstract][Full Text] [Related]
20. H19 serves as a diagnostic biomarker and up-regulation of H19 expression contributes to poor prognosis in patients with gastric cancer.
Chen JS; Wang YF; Zhang XQ; Lv JM; Li Y; Liu XX; Xu TP
Neoplasma; 2016; 63(2):223-30. PubMed ID: 26774144
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
